Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Penumbra, Inc.
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
October 29, 2026
Penumbra’s CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
October 20, 2026
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
October 6, 2026
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
August 19, 2026
Penumbra, Inc. Reports First Quarter 2026 Financial Results
May 6, 2026